Page 112 - MemoriaES-Eng

RESEARCH GROUPS

í

íó

íá
íí
óé
ó
í

í
í
éíí
ííí
íí

PROGRAMME:
éúñó
Group 9
éé
Tuberculosis / New
Therapeutic Targets

Lead Researcher
Group Members

STAFF MEMBERS
Martín Montañés, Carlos
Cebollada Solanas, Alberto

Lampreave Carrillo, Carlos
Contact:
ASSOCIATED MEMBERS
Departamento de Microbiología. Facultad de Medicina.
Universidad de Zaragoza. Aguil Anento, Ignacio
Ansa Claver, Jos Antonio
Calle Pedro Cerbuna, 12. Zaragoza · Phone: (+34) 976 761 759
E.mail: [email protected] · Website: [email protected]
Alonso Ezcurra, Mara Henar
Arbus Arribas, Ainhoa

Das Rodrgues, Liliana Isabel
Main lines of research
Gavn Benavent, Patricia
Gmez Aguirre, Ana Beln

Gmez Lus, Rafael Our Research Group of Mycobacterial Genetics has been working since 1992 in
Gonzalo Asensio, Jess four lines of research financed by European and national investigation funds and

Graca Daz, Begoa that has permitted it to acquire an internationally recognized prestige. These lines
Ibarz Bosqued, Daniel of research include:

Iglesias Gozalo, Mara Jos 1 - Construction of New Vaccines against Tuberculosis 2 - Molecular Epidemiology

Lafoz Pueyo, Carmen of Tuberculosis & Transposition and Latency of M. tuberculosis 3 - Molecular Bases
Lezcano Carrera, Mara Antonia of the Resistance of mycobacteria.

Luca Quintana, Ainhoa The objectives of our group are to study the complexity of M. tuberculosis in a í
Milln Lou, Mara Isabel
multidisciplinary focus and our group is coordinated with other national and inter-
Otal Gil, Isabel national groups. More concretely we focus our research in: 1 - Genes implicated
Pico Marco, Ana
in the pathogenicity and virulence of M. tuberculosis 2 - Molecular epidemiology
Revillo Pinilla, Mara Jos of tuberculosis, risk factors of transmission, and differences between strains of
Rubio Calvo, Mara Carmen 13
major epidemiological importance and the mechanism of slow growth of the Koch 20
Samper Blasco, Sofa Luisa bacillus 3 - Mechanisms of resistance. Projects:
T
R
Solans Bernad, Luis • Line 1: NEW TBVAC 241745 FP7, ECDTP (TBTEA) FP7 TBTEA. 2011- 2013 PO
Villellas Arilla, Mara Cristina E
BIO2011-23555 BIO2011-23555 MCyT/DGI/FEDER 2012-2014. INNPACTO: Ref. L R
Vitoria Agreda, Ma Asuncin
IPT-2012-0327-090000 Ministerio de Economa y Competitividad “BIOFABRI.
A
NU
• Line 2: FIS, Instituto de Salud Carlos III. 2013- 2015.REFBIO. 2013- 2014 Net- N
A
work: European reference laboratory network for tuberculosis (ERLTB-Net) - to /
strengthen TB diagnosis, drug susceptibility testing and coordination at Euro- ES
ER
pean Union.
B
CI
•Line3. Ref:GRANT/2013/003.ECDC.2014.Line33:MM4TBMoreMedicinesfor
Tuberculosis. European Union 2011-2014 NAREB - Nanotherapeutics for antibio-
112
tic resistant emerging bacterial pathogens European Union. 2014- 2018.